Etarotene

CAS No. 87719-32-2

Etarotene( —— )

Catalog No. M34077 CAS No. 87719-32-2

Etarotene (Arotinoid ethyl sulphone) is an ethylsulfonyl derivative of aloe acid with differentiation-inducing and potentially antitumor activity.Etarotene is a collagenase inhibitor and can be used to study psoriasis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 392 Get Quote
5MG 610 Get Quote
10MG 867 Get Quote
25MG 1260 Get Quote
50MG 1702 Get Quote
100MG 2250 Get Quote
500MG 4410 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Etarotene
  • Note
    Research use only, not for human use.
  • Brief Description
    Etarotene (Arotinoid ethyl sulphone) is an ethylsulfonyl derivative of aloe acid with differentiation-inducing and potentially antitumor activity.Etarotene is a collagenase inhibitor and can be used to study psoriasis.
  • Description
    Etarotene (Arotinoid ethyl sulphone) is an ethylsulfonyl derivative of aloe acid with differentiation-inducing and potentially antitumor activity.Etarotene is a collagenase inhibitor and can be used to study psoriasis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Tyrosinase
  • Recptor
    Tyrosinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    87719-32-2
  • Formula Weight
    396.59
  • Molecular Formula
    C25H32O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1(C)C=2C(C(C)(C)CC1)=CC=C(\C(=C\C3=CC=C(S(CC)(=O)=O)C=C3)\C)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ME0328

    ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about 7-fold selectivity over PARP1.

  • NDI-034858

    NDI-034858 (TAK-279) is a tyrosine kinase 2 (TYK2) inhibitor (Kd<200 pM) that targets the JH2 structural domain of Tyk2 for the treatment of autoimmune diseases caused by aberrant expression of IL12 and IL23.

  • AMG 925

    AMG 925 is a potent and orally bioavailable dual FLT3/CDK4 inhibitor with IC50 of 1 nM and 3 nM, respectively.